Comprehensive technical exploration of the challenges in targeting ion channels with antibodies, their structural...
Blog categories
Blog Search
Latest posts
View all →-
Ion channels as therapeutic antibody targets: development challenges and opportunitiesRead more ... -
Antibodies and Venom Peptides: New Tools to Target Ion ChannelsRead more ...Ion channels play fundamental roles in both excitable and non-excitable tissues, making them attractive molecular...
-
RNA ELISA Kits: Laboratory Principles, Workflow Innovations, and Analytical ApplicationsRead more ...Explore the comprehensive technical framework of RNA ELISA kits, detailing modern innovations in sensitivity,...
-
Translational HIV Therapy: Overcoming Resistance via Gene KnockoutRead more ...Explore advanced translational research on overcoming viral escape mutations, targeting CCR5 host receptors, and...
-
Gene Editing Technologies in HIV Research: Mechanisms & ApplicationsRead more ...Discover how CRISPR/Cas9 and molecular gene editing tools are utilized in HIV research to target viral DNA, suppress...
Popular posts
-
RNA ELISA Kits: Laboratory Principles, Workflow Innovations, and Analytical ApplicationsExplore the comprehensive technical framework of RNA ELISA kits, detailing modern innovations in sensitivity,...Read more ...
-
Ion channels as therapeutic antibody targets: development challenges and opportunitiesComprehensive technical exploration of the challenges in targeting ion channels with antibodies, their structural...Read more ...
-
Understanding Polyclonal Antibodies: A Simple GuideDiscover what polyclonal antibodies are, how they are produced in the laboratory, their main applications, and key...Read more ... -
Antibodies and Venom Peptides: New Tools to Target Ion ChannelsIon channels play fundamental roles in both excitable and non-excitable tissues, making them attractive molecular...Read more ...
-
Translational HIV Therapy: Overcoming Resistance via Gene KnockoutExplore advanced translational research on overcoming viral escape mutations, targeting CCR5 host receptors, and...Read more ...
Featured posts
-
Ion channels as therapeutic antibody targets: development challenges and opportunitiesComprehensive technical exploration of the challenges in targeting ion channels with antibodies, their structural...Read more ...
-
Antibodies and Venom Peptides: New Tools to Target Ion ChannelsIon channels play fundamental roles in both excitable and non-excitable tissues, making them attractive molecular...Read more ...
-
RNA ELISA Kits: Laboratory Principles, Workflow Innovations, and Analytical ApplicationsExplore the comprehensive technical framework of RNA ELISA kits, detailing modern innovations in sensitivity,...Read more ...
-
Translational HIV Therapy: Overcoming Resistance via Gene KnockoutExplore advanced translational research on overcoming viral escape mutations, targeting CCR5 host receptors, and...Read more ...
-
Gene Editing Technologies in HIV Research: Mechanisms & ApplicationsDiscover how CRISPR/Cas9 and molecular gene editing tools are utilized in HIV research to target viral DNA, suppress...Read more ...
Subcategorieën
| Cat | Name | Size | Price | Action |
|---|---|---|---|---|
| GTR19277037 | Thalidomide-6-F-5-pip-CHO | - | € 0,00 | |
| GTR19298271 | Rabbit Anti-IA2 PcAb | - | € 1.035,50 | |
| GTR18834622 | Rat Malondialdehyde (MDA) ELISA Kit | - | € 711,50 | |
| GTR17766622 | Goat Anti-Human IgG H&L, HRP conjugated | - | € 137,50 | |
| GTR17766923 | Rabbit Anti-Biotin, Cy5 conjugated | - | € 765,50 | |
| GTR19023420 | Recombinant Human Follistatin-Related Protein 1/FSTL1 (C-6His, E. coli) | - | € 563,00 | |
| GTR19277624 | Ac-IETD-CHO TFA | - | € 684,50 | |
| GTR19298272 | Rabbit anti-human hemoglobin (HGB) McAb | - | € 657,50 | |
| GTR18834624 | Rat Macrophage-Derived Chemokine (MDC) ELISA Kit | - | € 711,50 | |
| GTR17766623 | Goat Anti-Mouse IgG H&L, Cy5 conjugated | - | € 185,00 | |
| GTR17766925 | Rabbit Anti-Biotin, Cy5.5 conjugated | - | € 765,50 | |
| GTR19023909 | Recombinant Human Galectin-7/LGALS7 (E. coli) | - | € 522,50 |